DiaMedica Therapeutics, Inc. DMAC
7.94
0.11
1.40%
as of 25 Sep
- Market cap
- $422.2M
- P/E
- 0.0×
Follow DMAC
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | — | — | 0.00 | — | — |
P/S ratio |
— | — | — | — | — | — | — | 0.00 | — | — |
P/FCF ratio |
— | — | — | — | — | — | — | 0.00 | — | — |
P/Operating CF |
— | — | — | — | — | — | — | (11.86) | — | — |
P/B ratio |
— | — | — | — | — | — | — | 1.32 | — | — |
Price to Tangible BV |
— | — | — | — | — | — | — | 1.32 | — | — |
EV/Sales |
— | — | — | — | — | — | — | 0.00 | — | — |
EV/EBITDA |
— | — | — | — | — | — | — | 0.00 | — | — |
EV/Operating CF |
— | — | — | — | — | — | — | (1.01) | — | — |
EV/FCF |
— | — | — | — | — | — | — | (1.00) | — | — |
Quick Ratio |
11.72 | 8.23 | 19.12 | 15.49 | 29.69 | 13.73 | 6.60 | 13.58 | 1.43 | 2.85 |
Current Ratio |
11.81 | 8.28 | 19.27 | 15.61 | 29.82 | 13.77 | 6.70 | 13.87 | 1.49 | 2.96 |
Net Debt/EBITDA |
1.70 | 1.58 | 2.36 | 2.39 | 3.35 | 2.17 | 0.68 | 2.49 | 0.30 | 0.70 |
Debt/Assets |
0.01% | 0.03% | 0.00% | 0.01% | 0.01% | 0.02% | 0.14% | 0.10% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 |
Operating CF/Net income |
0.89 | 0.90 | 0.97 | 0.84 | 0.90 | 0.75 | 0.85 | 0.99 | 0.92 | 1.36 |
Capex/Depreciation |
0.04 | 0.02 | 0.02 | (5.79) | (0.11) | (1.82) | (0.21) | (3.33) | (5.50) | (3.14) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (67.68%) | (53.27%) | (46.77%) | (36.06%) | (38.81%) | (73.10%) | (86.43%) | (64.34%) | (416.63%) | (33,683.33%) | |
| (60.84%) | (48.64%) | (43.77%) | (34.21%) | (36.91%) | (66.18%) | (77.75%) | (56.94%) | (231.84%) | (212.13%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1,920.74%) | 0.00% | 0.00% |
Return on Tangible Assets |
(58.89%) | (62.09%) | (37.99%) | (43.00%) | (30.90%) | (47.34%) | (140.45%) | (34.19%) | (806.82%) | (178.42%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 569.40 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 904.40% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 547.80% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 124.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | — | — | — | — | 0.74 | — | — |
Graham Number |
— | — | — | — | — | — | — | 0.00 | — | — |
Earnings Yield |
— | — | — | — | — | — | — | (25.44%) | — | — |
Free Cash Flow Yield |
— | — | — | — | — | — | — | (25.50%) | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
Operating CF per Share |
(0.62) | (0.55) | (0.58) | (0.44) | (0.59) | (0.59) | (0.76) | (0.74) | (0.66) | (0.64) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.01) | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.62) | (0.55) | (0.58) | (0.44) | (0.59) | (0.59) | (0.76) | (0.74) | (0.66) | (0.64) |
Cash per Share |
1.27 | 1.09 | 1.62 | 1.27 | 2.17 | 1.75 | 0.66 | 2.17 | 0.23 | 0.37 |
Shareholders Equity per Share |
1.19 | 1.01 | 1.57 | 1.20 | 2.12 | 1.66 | 0.64 | 2.20 | 0.13 | 0.26 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.19 | 1.01 | 1.57 | 1.20 | 2.12 | 1.66 | 0.64 | 2.20 | 0.13 | 0.26 |
Free Cash Flow |
(29.10) | (22.10) | (18.75) | (11.59) | (12.27) | (9.22) | (9.09) | (5.75) | (3.92) | (3.03) |
Working Capital |
55.50 | 39.22 | 50.89 | 31.67 | 43.92 | 25.89 | 7.52 | 16.68 | 0.49 | 1.23 |
Capital Expenditures |
(0.04) | (0.02) | (0.02) | (0.08) | (0.02) | (0.03) | 0.01 | (0.05) | (0.02) | (0.01) |
Net Current Asset Value |
55.37 | 38.98 | 50.57 | 31.27 | 43.91 | 25.84 | 7.40 | 16.66 | 0.49 | 1.23 |
EV/EBIT |
— | — | — | — | — | — | — | 0.00 | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1,146.80%) | 0.00% | 0.00% |
Price to Operating Income |
— | — | — | — | — | — | — | 0.00 | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
(6.20) | (8.81) | (9.11) | 0.10 | 2.64 | 0.23 | (0.83) | 0.16 | 0.11 | 0.11 |
Cash ROIC |
(25.18%) | (26.18%) | (18.14%) | (17.83%) | (13.82%) | (17.30%) | (59.10%) | (17.10%) | (182.95%) | (102.02%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.16 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Average Receivables |
0.25 | 0.30 | 0.23 | 0.11 | 0.24 | 0.58 | 0.80 | 0.43 | 0.07 | 0.03 |
Average Payables |
1.21 | 0.93 | 0.83 | 0.62 | 0.80 | 0.64 | 0.33 | 0.70 | 0.77 | 0.83 |
Average Assets |
53.86 | 50.25 | 44.28 | 39.97 | 36.82 | 18.57 | 13.70 | 10.07 | 1.84 | 1.05 |
Average Common Equity |
48.41 | 45.89 | 41.44 | 37.93 | 35.02 | 16.82 | 12.32 | 8.91 | 1.02 | 0.01 |
Columns are period end dates